Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results

Deployed new digital chemistry technology, together with NVIDIA, to predict the ligand-protein interactions for approximately 36 billion compounds in the Enamine REAL Space, reported to be the...

Related Keywords

Utah ,United States ,Canada ,Toronto ,Ontario ,Salt Lake City ,Canadian ,Wilson Sonsini Goodrich Rosati ,Chris Gibson ,Morningstar Sustainalytics ,Nathan Hatfield ,David Mauro ,Toronto Office ,Foundation Model Construction ,Partnership Value ,Twitter ,Exchange Commission ,International Conference For Machine ,Nvidia ,Development Expenses ,Recursion Pharmaceuticals Inc ,Linkedin ,Cavernous Malformation ,Adenomatous Polyposis ,Proficient Ovarian Cancer ,Target Gamma ,Valence Discovery ,Model Construction ,Language Models ,International Conference ,Machine Learning ,Valence Labs ,Medical Officer ,Chief Medical ,New Drug ,Legal Officer ,Chief Legal ,Wilson Sonsini Goodrich ,Canadian Headquarters ,Administrative Expenses ,San Francisco Bay ,Consolidated Statements ,Consolidated Balance Sheets ,Securities Litigation Reform Act ,Quarterly Report ,Annual Report ,Markets ,